Gene therapy approvals mark a medical milestone. Valuable lessons learned from breakthroughs guide us toward responsible innovation. Collaboration is key for advancing gene therapy and overcoming challenges. #GeneTherapy #MedicalInnovation #Collaboration h
A decade of Gene Therapy Drug Development and what has been learned @Nature #GeneTherapy https://t.co/xHyTjzF8IU
RT @NikoMcCarty: We are living through the golden age of gene therapies. In 2018, more than 200 Investigational New Drug (IND) application…
RT @NikoMcCarty: We are living through the golden age of gene therapies. In 2018, more than 200 Investigational New Drug (IND) application…
RT @NikoMcCarty: We are living through the golden age of gene therapies. In 2018, more than 200 Investigational New Drug (IND) application…
RT @NikoMcCarty: We are living through the golden age of gene therapies. In 2018, more than 200 Investigational New Drug (IND) application…
RT @NikoMcCarty: We are living through the golden age of gene therapies. In 2018, more than 200 Investigational New Drug (IND) application…
RT @NikoMcCarty: We are living through the golden age of gene therapies. In 2018, more than 200 Investigational New Drug (IND) application…
Tıp 2:0 devrimi başladı! Genetik hastalıklar artık tedavi edilebiliyor. Gen ve RNA terapilerinin hayat bulduğu bu devrimde neredeyiz? Detayları burda: Tıp 2.0 : GEN ve RNA Terapi | Kitapyurdu https://t.co/m14H9qZlS4
RT @NikoMcCarty: We are living through the golden age of gene therapies. In 2018, more than 200 Investigational New Drug (IND) application…
RT @NikoMcCarty: We are living through the golden age of gene therapies. In 2018, more than 200 Investigational New Drug (IND) application…
RT @NikoMcCarty: We are living through the golden age of gene therapies. In 2018, more than 200 Investigational New Drug (IND) application…
RT @NikoMcCarty: We are living through the golden age of gene therapies. In 2018, more than 200 Investigational New Drug (IND) application…
RT @NikoMcCarty: We are living through the golden age of gene therapies. In 2018, more than 200 Investigational New Drug (IND) application…
RT @NikoMcCarty: We are living through the golden age of gene therapies. In 2018, more than 200 Investigational New Drug (IND) application…
RT @NikoMcCarty: We are living through the golden age of gene therapies. In 2018, more than 200 Investigational New Drug (IND) application…
RT @NikoMcCarty: We are living through the golden age of gene therapies. In 2018, more than 200 Investigational New Drug (IND) application…
RT @NikoMcCarty: We are living through the golden age of gene therapies. In 2018, more than 200 Investigational New Drug (IND) application…
RT @NikoMcCarty: We are living through the golden age of gene therapies. In 2018, more than 200 Investigational New Drug (IND) application…
We are living through the golden age of gene therapies. In 2018, more than 200 Investigational New Drug (IND) applications involving a gene therapy product were submitted to the F.D.A. Chart for an upcoming @AsimovBio blog... https://t.co/rvB7jt9jxz htt
It's clear that #genetheraphy “is now giving rise to treatments for diseases that have not previously been treatable, & to life-altering treatments for diseases that had previously demanded Herculean efforts from the patient & the family.” #RareDis
Also see the companion article from Dr. Kathy High reviewing the last decade of gene therapy. https://t.co/egahS1YSfQ
In the past decade, gene and cell therapy products have provided new therapeutic options for single gene disorders and for hematologic malignancies. Informative @NatureComms review of promise and limitations. https://t.co/WbklzhG3Ct https://t.co/jfKImDFKm8
RT @Primary_Immune: 🧬 A nice update on gene therapy '2.0' ...like the ring of "genes as medicines" :-) https://t.co/R9oSsjAVeP #opensc…
RT @Primary_Immune: 🧬 A nice update on gene therapy '2.0' ...like the ring of "genes as medicines" :-) https://t.co/R9oSsjAVeP #opensc…
RT @Primary_Immune: 🧬 A nice update on gene therapy '2.0' ...like the ring of "genes as medicines" :-) https://t.co/R9oSsjAVeP #opensc…
RT @Primary_Immune: 🧬 A nice update on gene therapy '2.0' ...like the ring of "genes as medicines" :-) https://t.co/R9oSsjAVeP #opensc…
RT @Primary_Immune: 🧬 A nice update on gene therapy '2.0' ...like the ring of "genes as medicines" :-) https://t.co/R9oSsjAVeP #opensc…
RT @Primary_Immune: 🧬 A nice update on gene therapy '2.0' ...like the ring of "genes as medicines" :-) https://t.co/R9oSsjAVeP #opensc…
RT @Primary_Immune: 🧬 A nice update on gene therapy '2.0' ...like the ring of "genes as medicines" :-) https://t.co/R9oSsjAVeP #opensc…
RT @Primary_Immune: 🧬 A nice update on gene therapy '2.0' ...like the ring of "genes as medicines" :-) https://t.co/R9oSsjAVeP #opensc…
🧬 A nice update on gene therapy '2.0' ...like the ring of "genes as medicines" :-) https://t.co/R9oSsjAVeP #openscience #datascience #bigdata #rstats #technology #biotech #itrtg #genomics #raredisease https://t.co/EMUZn1AXBO
Gene and cell therapy. Looking back moving forward @NatureComms https://t.co/jKIt7uR64i